Compton Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,365
| Closed | -$248K | – | 55 |
|
|
2022
Q4 | $248K | Sell |
5,365
-500
| -9% | -$23.1K | 0.18% | 68 |
|
|
2022
Q3 | $227K | Sell |
5,865
-125
| -2% | -$4.84K | 0.15% | 76 |
|
|
2022
Q2 | $223K | Sell |
5,990
-1,500
| -20% | -$55.8K | 0.12% | 92 |
|
|
2022
Q1 | $332K | Hold |
7,490
| – | – | 0.09% | 138 |
|
|
2021
Q4 | $318K | Hold |
7,490
| – | – | 0.08% | 142 |
|
|
2021
Q3 | $325K | Sell |
7,490
-270
| -3% | -$11.7K | 0.1% | 138 |
|
|
2021
Q2 | $332K | Buy |
7,760
+175
| +2% | +$7.49K | 0.1% | 134 |
|
|
2021
Q1 | $293K | Buy |
7,585
+75
| +1% | +$2.9K | 0.09% | 134 |
|
|
2020
Q4 | $270K | Buy |
7,510
+350
| +5% | +$12.6K | 0.09% | 129 |
|
|
2020
Q3 | $274K | Sell |
7,160
-300
| -4% | -$11.5K | 0.11% | 116 |
|
|
2020
Q2 | $262K | Buy |
7,460
+300
| +4% | +$10.5K | 0.11% | 114 |
|
|
2020
Q1 | $234K | Buy |
7,160
+600
| +9% | +$19.6K | 0.12% | 114 |
|
|
2019
Q4 | $297K | Buy |
+6,560
| New | +$297K | 0.12% | 115 |
|